D.E. Shaw & Co
KITE

D.E. Shaw & Co’s Kite Pharma, Inc. KITE Stock Holding History

D.E. Shaw & Co’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-60,000
Closed -$10.8M – 3896
2017
Q3 		$10.8M Hold
60,000
– – 0.02% 898
2017
Q2 		$6.22M Buy
60,000
+50,000
+500% +$4.08M 0.01% 1187
2017
Q1 		$785K Buy
+10,000
New +$618K ﹤0.01% 2472

D.E. Shaw & Co's KITE Position: Q4 2017 in Review

D.E. Shaw & Co sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 39,106 shares — an estimated $7.03M sold.

D.E. Shaw & Co first reported a position in KITE in Q1 2015 and held it in 9 quarters. The position peaked at $7.03M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • D.E. Shaw & Co reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • D.E. Shaw & Co sold 39,106 Kite Pharma, Inc. shares in Q4 2017, an estimated $7.03M.
  • D.E. Shaw & Co first reported a position in Kite Pharma, Inc. in Q1 2015 and held it in 9 quarters.
  • D.E. Shaw & Co's Kite Pharma, Inc. position peaked at $7.03M in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on D.E. Shaw & Co's 13F filing for Q4 2017, filed 14 Feb 2018.